Zdrowie i gospodarka · 17/02/2009
FDA Releases Draft Guidance on Nonclinical Evaluation for Anticancer Pharmaceuticals
The FDA has made available a draft guidance document outlining internationally accepted recommendations for nonclinical studies to support the development of anticancer pharmaceuticals, developed in collaboration with the International Conference on Harmonisation.
Source: Federal Register — Food and Drug AdministrationOpen original release →